Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS

Yung Feng Yen, Marcelo Chen, I. An Jen, Pei Hung Chuang, Chun Yuan Lee, Su I. Lin, Yi Ming Arthur Chen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Highly active antiretroviral therapy (HAART) causes a rapid increase of CD4 + T cells counts during the first 3–6 months of treatment and may enhance the development of opportunistic infections (OIs). However, the short- and long-term effects of HAART exposure on the development of incident OIs has not been extensively studied. This nationwide longitudinal study followed up a total of 26,258 people living with HIV/AIDS (PLWHA) to ascertain the short- and long-term effects of HAART on incident OIs. During 150,196 person-years of follow-up, 6,413 (24.4%) PLWHA had new onset of OIs. After adjusting for demographics, comorbidities, and AIDS status, PLWHA who received HAART were more likely to develop OIs than those who did not receive HAART. Considering the short- and long-term effects of HAART on the development of OIs, HAART was found to be a risk factor for developing OIs during the first 90 days of treatment, but a protective factor against OIs after 180 days of HAART use. The risk for the development of active OIs significantly decreased as the duration of HAART increased (P < 0.001). Our study suggests that HAART is a risk factor for developing OIs in the short term, but is a protective factor in the long term.

Original languageEnglish
Article number3476
JournalScientific Reports
Volume9
Issue number1
DOIs
Publication statusPublished - Dec 1 2019

Fingerprint

Opportunistic Infections
Highly Active Antiretroviral Therapy
Acquired Immunodeficiency Syndrome
HIV
Therapeutics
CD4 Lymphocyte Count
Longitudinal Studies
Comorbidity
Demography
T-Lymphocytes

ASJC Scopus subject areas

  • General

Cite this

Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS. / Yen, Yung Feng; Chen, Marcelo; Jen, I. An; Chuang, Pei Hung; Lee, Chun Yuan; Lin, Su I.; Chen, Yi Ming Arthur.

In: Scientific Reports, Vol. 9, No. 1, 3476, 01.12.2019.

Research output: Contribution to journalArticle

Yen, Yung Feng ; Chen, Marcelo ; Jen, I. An ; Chuang, Pei Hung ; Lee, Chun Yuan ; Lin, Su I. ; Chen, Yi Ming Arthur. / Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS. In: Scientific Reports. 2019 ; Vol. 9, No. 1.
@article{9dce2ef4f7b44b4fa56b39cd309076dd,
title = "Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS",
abstract = "Highly active antiretroviral therapy (HAART) causes a rapid increase of CD4 + T cells counts during the first 3–6 months of treatment and may enhance the development of opportunistic infections (OIs). However, the short- and long-term effects of HAART exposure on the development of incident OIs has not been extensively studied. This nationwide longitudinal study followed up a total of 26,258 people living with HIV/AIDS (PLWHA) to ascertain the short- and long-term effects of HAART on incident OIs. During 150,196 person-years of follow-up, 6,413 (24.4{\%}) PLWHA had new onset of OIs. After adjusting for demographics, comorbidities, and AIDS status, PLWHA who received HAART were more likely to develop OIs than those who did not receive HAART. Considering the short- and long-term effects of HAART on the development of OIs, HAART was found to be a risk factor for developing OIs during the first 90 days of treatment, but a protective factor against OIs after 180 days of HAART use. The risk for the development of active OIs significantly decreased as the duration of HAART increased (P < 0.001). Our study suggests that HAART is a risk factor for developing OIs in the short term, but is a protective factor in the long term.",
author = "Yen, {Yung Feng} and Marcelo Chen and Jen, {I. An} and Chuang, {Pei Hung} and Lee, {Chun Yuan} and Lin, {Su I.} and Chen, {Yi Ming Arthur}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-39665-6",
language = "English",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS

AU - Yen, Yung Feng

AU - Chen, Marcelo

AU - Jen, I. An

AU - Chuang, Pei Hung

AU - Lee, Chun Yuan

AU - Lin, Su I.

AU - Chen, Yi Ming Arthur

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Highly active antiretroviral therapy (HAART) causes a rapid increase of CD4 + T cells counts during the first 3–6 months of treatment and may enhance the development of opportunistic infections (OIs). However, the short- and long-term effects of HAART exposure on the development of incident OIs has not been extensively studied. This nationwide longitudinal study followed up a total of 26,258 people living with HIV/AIDS (PLWHA) to ascertain the short- and long-term effects of HAART on incident OIs. During 150,196 person-years of follow-up, 6,413 (24.4%) PLWHA had new onset of OIs. After adjusting for demographics, comorbidities, and AIDS status, PLWHA who received HAART were more likely to develop OIs than those who did not receive HAART. Considering the short- and long-term effects of HAART on the development of OIs, HAART was found to be a risk factor for developing OIs during the first 90 days of treatment, but a protective factor against OIs after 180 days of HAART use. The risk for the development of active OIs significantly decreased as the duration of HAART increased (P < 0.001). Our study suggests that HAART is a risk factor for developing OIs in the short term, but is a protective factor in the long term.

AB - Highly active antiretroviral therapy (HAART) causes a rapid increase of CD4 + T cells counts during the first 3–6 months of treatment and may enhance the development of opportunistic infections (OIs). However, the short- and long-term effects of HAART exposure on the development of incident OIs has not been extensively studied. This nationwide longitudinal study followed up a total of 26,258 people living with HIV/AIDS (PLWHA) to ascertain the short- and long-term effects of HAART on incident OIs. During 150,196 person-years of follow-up, 6,413 (24.4%) PLWHA had new onset of OIs. After adjusting for demographics, comorbidities, and AIDS status, PLWHA who received HAART were more likely to develop OIs than those who did not receive HAART. Considering the short- and long-term effects of HAART on the development of OIs, HAART was found to be a risk factor for developing OIs during the first 90 days of treatment, but a protective factor against OIs after 180 days of HAART use. The risk for the development of active OIs significantly decreased as the duration of HAART increased (P < 0.001). Our study suggests that HAART is a risk factor for developing OIs in the short term, but is a protective factor in the long term.

UR - http://www.scopus.com/inward/record.url?scp=85062524732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062524732&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-39665-6

DO - 10.1038/s41598-019-39665-6

M3 - Article

C2 - 30837537

AN - SCOPUS:85062524732

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 3476

ER -